Related Experiment Video
Updated: Nov 11, 2025

08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.6K
Hybrid Therapy for Metastatic Disease.
Zach Pennington1, Jeff Ehresman1, Nicholas J Szerlip2
1Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD.
Clinical Spine Surgery
|March 26, 2021
Summary
Minimally invasive separation surgery is increasingly used for spinal metastases to decompress nerves and stabilize the spine. This approach supports radiation therapy, improving patient quality-of-life.
Area of Science:
- Oncology
- Neurosurgery
- Orthopedic Surgery
Background:
- Metastatic spine disease presents complex challenges requiring multidisciplinary care.
- Advancements in radiation technology have shifted surgery's role to an adjuvant therapy.
- Patient frailty necessitates minimally invasive surgical approaches.
Purpose of the Study:
- To explore the role and techniques of minimally invasive surgery for spinal metastases.
- To highlight separation surgery's goals in managing spinal tumors.
- To emphasize optimizing patient quality-of-life in treatment planning.
Main Methods:
- Review of minimally invasive surgical techniques for spinal metastases.
- Focus on separation surgery principles: decompression, stability, and radiation facilitation.
- Multidisciplinary team approach in treatment strategy formulation.
Main Results:
- Minimally invasive techniques, including separation surgery, are increasingly adopted for spinal metastases.
- Separation surgery aims to decompress neural elements and provide mechanical stability.
- These techniques facilitate effective high-dose radiation delivery while minimizing spinal cord toxicity.
Conclusions:
- Minimally invasive separation surgery is a key component in the multidisciplinary management of spinal metastases.
- This approach enhances the ability to deliver radiation therapy effectively.
- The focus on minimal invasiveness improves outcomes and quality-of-life for frail patients with spinal tumors.
Related Concept Videos
Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
Tumor Immunotherapy
820
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
820
Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Cancer Therapies
8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Metastasis
6.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K

